vs
Arcellx, Inc.（ACLX）与爱齐科技（ALGN）财务数据对比。点击上方公司名可切换其他公司
爱齐科技的季度营收约是Arcellx, Inc.的633.4倍（$1.0B vs $1.7M）。爱齐科技净利率更高（13.0% vs -3513.4%，领先3526.4%）。爱齐科技同比增速更快（5.3% vs -89.2%）。爱齐科技自由现金流更多（$187.3M vs $-58.9M）。过去两年爱齐科技的营收复合增速更高（2.5% vs -79.5%）
Arcellx, Inc.是一家处于临床阶段的生物技术企业，专注开发用于治疗血液恶性肿瘤、实体瘤等难治性癌症的CAR-T细胞疗法，其核心管线针对肿瘤领域未被满足的医疗需求，服务全球患者群体。
爱齐科技是一家全球知名医疗设备企业，主营设计、生产及销售隐适美透明矫治器、iTero口内扫描仪及配套服务，客户覆盖正畸医师、全科牙医，面向修复、美容牙科领域，业务分为透明矫治器、扫描仪及服务两大板块，可满足青少年等不同群体的正畸需求
ACLX vs ALGN — 直观对比
营收规模更大
ALGN
是对方的633.4倍
$1.7M
营收增速更快
ALGN
高出94.4%
-89.2%
净利率更高
ALGN
高出3526.4%
-3513.4%
自由现金流更多
ALGN
多$246.2M
$-58.9M
两年增速更快
ALGN
近两年复合增速
-79.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7M | $1.0B |
| 净利润 | $-58.1M | $135.8M |
| 毛利率 | — | 65.3% |
| 营业利润率 | -3850.2% | 14.8% |
| 净利率 | -3513.4% | 13.0% |
| 营收同比 | -89.2% | 5.3% |
| 净利润同比 | -23.4% | 30.8% |
| 每股收益（稀释后） | $-1.01 | $1.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACLXALGN
| Q4 25 | $1.7M | $1.0B | ||
| Q3 25 | $4.9M | $995.7M | ||
| Q2 25 | $7.6M | $1.0B | ||
| Q1 25 | $8.1M | $979.3M | ||
| Q4 24 | $15.3M | $995.2M | ||
| Q3 24 | $26.0M | $977.9M | ||
| Q2 24 | $27.4M | $1.0B | ||
| Q1 24 | $39.3M | $997.4M |
净利润ACLXALGN
| Q4 25 | $-58.1M | $135.8M | ||
| Q3 25 | $-55.8M | $56.8M | ||
| Q2 25 | $-52.8M | $124.6M | ||
| Q1 25 | $-62.3M | $93.2M | ||
| Q4 24 | $-47.1M | $103.8M | ||
| Q3 24 | $-25.9M | $116.0M | ||
| Q2 24 | $-27.2M | $96.6M | ||
| Q1 24 | $-7.2M | $105.0M |
毛利率ACLXALGN
| Q4 25 | — | 65.3% | ||
| Q3 25 | — | 64.2% | ||
| Q2 25 | — | 69.9% | ||
| Q1 25 | — | 69.5% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 69.7% | ||
| Q2 24 | — | 70.3% | ||
| Q1 24 | — | 70.0% |
营业利润率ACLXALGN
| Q4 25 | -3850.2% | 14.8% | ||
| Q3 25 | -1248.3% | 9.7% | ||
| Q2 25 | -777.4% | 16.1% | ||
| Q1 25 | -847.6% | 13.4% | ||
| Q4 24 | -348.2% | 14.5% | ||
| Q3 24 | -129.1% | 16.6% | ||
| Q2 24 | -127.8% | 14.3% | ||
| Q1 24 | -40.3% | 15.5% |
净利率ACLXALGN
| Q4 25 | -3513.4% | 13.0% | ||
| Q3 25 | -1127.1% | 5.7% | ||
| Q2 25 | -698.6% | 12.3% | ||
| Q1 25 | -766.0% | 9.5% | ||
| Q4 24 | -308.4% | 10.4% | ||
| Q3 24 | -99.4% | 11.9% | ||
| Q2 24 | -99.3% | 9.4% | ||
| Q1 24 | -18.3% | 10.5% |
每股收益（稀释后）ACLXALGN
| Q4 25 | $-1.01 | $1.88 | ||
| Q3 25 | $-0.99 | $0.78 | ||
| Q2 25 | $-0.94 | $1.72 | ||
| Q1 25 | $-1.13 | $1.27 | ||
| Q4 24 | $-0.87 | $1.40 | ||
| Q3 24 | $-0.48 | $1.55 | ||
| Q2 24 | $-0.51 | $1.28 | ||
| Q1 24 | $-0.14 | $1.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $450.3M | $1.1B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $402.4M | $4.0B |
| 总资产 | $604.0M | $6.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACLXALGN
| Q4 25 | $450.3M | $1.1B | ||
| Q3 25 | $461.4M | $1.0B | ||
| Q2 25 | $453.1M | $901.2M | ||
| Q1 25 | $543.3M | $873.0M | ||
| Q4 24 | $587.4M | $1.0B | ||
| Q3 24 | $574.3M | $1.0B | ||
| Q2 24 | $516.7M | $761.4M | ||
| Q1 24 | $573.9M | $865.8M |
股东权益ACLXALGN
| Q4 25 | $402.4M | $4.0B | ||
| Q3 25 | $440.8M | $4.0B | ||
| Q2 25 | $392.2M | $3.9B | ||
| Q1 25 | $416.9M | $3.8B | ||
| Q4 24 | $454.8M | $3.9B | ||
| Q3 24 | $483.0M | $3.9B | ||
| Q2 24 | $487.2M | $3.8B | ||
| Q1 24 | $496.6M | $3.8B |
总资产ACLXALGN
| Q4 25 | $604.0M | $6.2B | ||
| Q3 25 | $655.9M | $6.2B | ||
| Q2 25 | $619.1M | $6.2B | ||
| Q1 25 | $648.1M | $6.1B | ||
| Q4 24 | $711.3M | $6.2B | ||
| Q3 24 | $764.9M | $6.4B | ||
| Q2 24 | $734.3M | $6.2B | ||
| Q1 24 | $779.7M | $6.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-58.2M | $223.2M |
| 自由现金流经营现金流 - 资本支出 | $-58.9M | $187.3M |
| 自由现金流率自由现金流/营收 | -3563.4% | 17.9% |
| 资本支出强度资本支出/营收 | 46.2% | 3.4% |
| 现金转化率经营现金流/净利润 | — | 1.64× |
| 过去12个月自由现金流最近4个季度 | $-212.6M | $490.8M |
8季度趋势，按日历期对齐
经营现金流ACLXALGN
| Q4 25 | $-58.2M | $223.2M | ||
| Q3 25 | $-49.2M | $188.7M | ||
| Q2 25 | $-39.7M | $128.7M | ||
| Q1 25 | $-63.1M | $52.7M | ||
| Q4 24 | $-46.0M | $286.1M | ||
| Q3 24 | $30.7M | $263.7M | ||
| Q2 24 | $-36.2M | $159.8M | ||
| Q1 24 | $-31.9M | $28.7M |
自由现金流ACLXALGN
| Q4 25 | $-58.9M | $187.3M | ||
| Q3 25 | $-49.5M | $169.0M | ||
| Q2 25 | $-40.2M | $107.2M | ||
| Q1 25 | $-63.9M | $27.4M | ||
| Q4 24 | $-47.5M | $263.1M | ||
| Q3 24 | $28.4M | $233.9M | ||
| Q2 24 | $-39.5M | $106.4M | ||
| Q1 24 | $-38.3M | $19.3M |
自由现金流率ACLXALGN
| Q4 25 | -3563.4% | 17.9% | ||
| Q3 25 | -1000.3% | 17.0% | ||
| Q2 25 | -532.4% | 10.6% | ||
| Q1 25 | -786.4% | 2.8% | ||
| Q4 24 | -311.3% | 26.4% | ||
| Q3 24 | 109.2% | 23.9% | ||
| Q2 24 | -144.1% | 10.3% | ||
| Q1 24 | -97.7% | 1.9% |
资本支出强度ACLXALGN
| Q4 25 | 46.2% | 3.4% | ||
| Q3 25 | 6.0% | 2.0% | ||
| Q2 25 | 6.4% | 2.1% | ||
| Q1 25 | 9.6% | 2.6% | ||
| Q4 24 | 9.8% | 2.3% | ||
| Q3 24 | 8.8% | 3.0% | ||
| Q2 24 | 11.7% | 5.2% | ||
| Q1 24 | 16.4% | 0.9% |
现金转化率ACLXALGN
| Q4 25 | — | 1.64× | ||
| Q3 25 | — | 3.33× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 0.57× | ||
| Q4 24 | — | 2.76× | ||
| Q3 24 | — | 2.27× | ||
| Q2 24 | — | 1.66× | ||
| Q1 24 | — | 0.27× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
